Sex, hormones, and Alzheimer's disease
- PMID: 15983176
- DOI: 10.1093/gerona/60.6.736
Sex, hormones, and Alzheimer's disease
Abstract
More women than men have Alzheimer's disease (AD). Retrospective studies suggested that hormone replacement therapy (HRT) might counteract this disparity by reducing the risk of developing dementia. However, a recent, large, prospective study revealed the puzzling result that HRT increased dementia risk. A review of the literature was conducted to generate hypotheses that might explain why more women than men have AD, and how HRT may increase dementia risk. Longer life span of women than men may be the largest factor in the preponderance of women with AD. Longer duration of disease, less vascular dementia, and less testosterone in women than men may also contribute somewhat. HRT might increase dementia risk by several mechanisms: greater risk of strokes, leading to dementia; use of medroxyprogesterone acetate and estrone, which might have somewhat different possible effects on neuronal and cerebrovascular function than may progesterone and estradiol; decrease of free testosterone which might protect against AD; a dose or delivery method perhaps producing drug levels that might lie outside a hypothetical beneficial range; and down-regulation of estrogen receptors on cholinergic neurons, possibly reducing cholinergic activity. Further study is required to discern by which of several possible mechanisms HRT increases dementia risk.
Similar articles
-
Is Hormone Replacement Therapy a Risk Factor or a Therapeutic Option for Alzheimer's Disease?Int J Mol Sci. 2023 Feb 6;24(4):3205. doi: 10.3390/ijms24043205. Int J Mol Sci. 2023. PMID: 36834617 Free PMC article. Review.
-
The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's disease.Drugs R D. 2006;7(3):187-93. doi: 10.2165/00126839-200607030-00004. Drugs R D. 2006. PMID: 16752944 Review.
-
Serum estradiol, progesterone, testosterone, FSH and LH levels in postmenopausal women with Alzheimer's dementia.Hell J Nucl Med. 2005 Jan-Apr;8(1):39-42. Hell J Nucl Med. 2005. PMID: 15886752 Clinical Trial.
-
[Hormonal replacement therapy and Alzheimer's disease. All quiet on the western front?].Psychol Neuropsychiatr Vieil. 2003 Dec;1(4):251-7. Psychol Neuropsychiatr Vieil. 2003. PMID: 15683960 Review. French.
-
Hormone replacement therapy to maintain cognitive function in women with dementia.Cochrane Database Syst Rev. 2002;(3):CD003799. doi: 10.1002/14651858.CD003799. Cochrane Database Syst Rev. 2002. Update in: Cochrane Database Syst Rev. 2009 Jan 21;(1):CD003799. doi: 10.1002/14651858.CD003799.pub2. PMID: 12137718 Updated. Review.
Cited by
-
Predictive value of hypercholesterolemia, vegetarian diet, and hypertension for incident dementia among elderly Taiwanese individuals with low educational levels.Ther Adv Chronic Dis. 2023 May 27;14:20406223231171549. doi: 10.1177/20406223231171549. eCollection 2023. Ther Adv Chronic Dis. 2023. PMID: 37255548 Free PMC article.
-
[Testosterone and Alzheimer's disease].Probl Endokrinol (Mosk). 2022 Jun 24;68(5):97-107. doi: 10.14341/probl13136. Probl Endokrinol (Mosk). 2022. PMID: 36337024 Free PMC article. Russian.
-
Targeting the non-classical estrogen pathway in neurodegenerative diseases and brain injury disorders.Front Endocrinol (Lausanne). 2022 Sep 15;13:999236. doi: 10.3389/fendo.2022.999236. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36187099 Free PMC article. Review.
-
Interaction of SARS-CoV-2 With RAS / ACE2 in the Female Reproductive System.J Family Reprod Health. 2022 Mar;16(1):1-8. doi: 10.18502/jfrh.v16i1.8588. J Family Reprod Health. 2022. PMID: 35903766 Free PMC article. Review.
-
Sex Differences in Cognition Across Aging.Curr Top Behav Neurosci. 2023;62:235-284. doi: 10.1007/7854_2022_309. Curr Top Behav Neurosci. 2023. PMID: 35467294 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical